Results for this period
Third quarter1 January 2026–30 September 2026ConsolidatedIFRSThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Revenue in the multi-purpose analytical instruments business declined as the impact of Trump policies in the United States continued. Revenue in the semiconductor process control equipment business increased on demand for memory and logic products, new product projects and growth in U.S. sales. Revenue in the parts and services business increased on growth in services and sales of other analytical instruments and parts. While efforts were made to control expenses, strategic investments, including research and development, continued, and a ¥759 million impairment loss was recognized on goodwill related to MILabs B.V.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–30 September 2026 |
| Net Sales | ¥60,691 million (YoY +2.0%) |
| Operating profit | ¥4,134 million (YoY -37.0%) |
| Ordinary income | ¥3,301 million (YoY -45.8%) |
| Profit attributable to owners of the parent | ¥2,479 million (YoY -42.0%) |
| Net income per share | ¥10.95 |
| Equity ratio | End of the current fiscal period 46.7 / End of previous period 47.7 |
| Total assets | ¥186,040 million |
| Net assets | ¥86,924 million |
| Cash flows from operating activities | ¥6,074 million |
| Cash flows from investing activities | ¥-3,833 million |
| Cash flows from financing activities | ¥128 million |
| Cash and cash equivalents at end of period | ¥26,466 million |
| Full-year earnings forecast | Net Sales ¥101,000 million (YoY +7.2%) / Operating profit ¥19,400 million (YoY +16.1%) / Ordinary income ¥18,400 million (YoY +15.2%) / Net income ¥12,500 million (YoY +9.6%) |
| Annual Dividend Forecast | ¥18.8 → ¥19（+1.1%） |
| Depreciation and amortization | ¥4,265 million |
| Impairment loss | ¥759 million |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement Not disclosed |
| Changes in the scope of consolidation | New Number of companies 2 / Company name Rigaku GmbH, Rigaku Canada Inc. / Excluded Number of companies 0 / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (for analysts and institutional investors) |
| Issued Shares at Period-End | 226,629,900 |
| Treasury Shares at Period-End | 19,601 |
| Factors Behind Changes in Business Performance | Revenue in the multi-purpose analytical instruments business declined as the impact of Trump policies in the United States continued. Revenue in the semiconductor process control equipment business increased on demand for memory and logic products, new product projects and growth in U.S. sales. Revenue in the parts and services business increased on growth in services and sales of other analytical instruments and parts. While efforts were made to control expenses, strategic investments, including research and development, continued, and a ¥759 million impairment loss was recognized on goodwill related to MILabs B.V. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The multi-purpose analytical instruments business continued to be affected by Trump policies in the United States. While efforts were made to control selling, general and administrative expenses, strategic investments, including research and development, continued. After considering future recoverability, the company recognized a ¥759 million impairment loss on goodwill related to MILabs B.V. The semiconductor process control equipment business benefited from demand for memory and logic products, new product projects and growth in U.S. sales.